TScan Therapeutics, Inc. (28) | Intellectual Property (3)
- Amended and Restated Exclusive Patent License Agreement by and between the Registrant and The Brigham and Womens Hospital, Inc. dated April 20, 2021 (Filed With SEC on April 23, 2021)
- Option & Exclusive License Agreement by and between the Registrant and QIAGEN Sciences LLC, dated as of November 5, 2020 (Filed With SEC on April 23, 2021)
- Non-Exclusive License Agreement by and between the Registrant and Provincial Health Services Authority, dated as of October 15, 2020 (Filed With SEC on April 23, 2021)